Cita APA (7a ed.)
Echigo, H., Munekane, M., Fuchigami, T., Washiyama, K., Mishiro, K., Wakabayashi, H., . . . Ogawa, K. (2024). Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European Journal of Nuclear Medicine & Molecular Imaging, 51(9), 2663-2672.
Cita Chicago Style (17a ed.)
Echigo, Hiroaki, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, y Kazuma Ogawa. "Optimizing the Pharmacokinetics of an 211At-labeled RGD Peptide with an Albumin-binding Moiety via the Administration of an Albumin-binding Inhibitor." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 9 (2024): 2663-2672.
Cita MLA (9a ed.)
Echigo, Hiroaki, et al. "Optimizing the Pharmacokinetics of an 211At-labeled RGD Peptide with an Albumin-binding Moiety via the Administration of an Albumin-binding Inhibitor." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 9, 2024, pp. 2663-2672.
Precaución: Estas citas no son 100% exactas.